You are here

Title

Pfizer Launches INVESTIGATE, a New Researcher Tool to Improve Clinical Trial Networking and Best Practices

Pfizer Launches INVESTIGATE, a New Researcher Tool to Improve Clinical Trial Networking and Best Practices

In drug development, Pfizer is continuously advancing new technology platforms and innovating with groundbreaking collaborations to bring safe and effective medicines to patients.  A critical step in that process is making clinical trials more transparent and providing healthcare professionals and researchers with the right tools to support the delivery of high quality trials. Drawing on experienced investigators’ knowledge and feedback, Pfizer’s Clinical Trial Support and Compliance organization recently launched INVESTIGATE, an informative platform that provides an interface between external investigator sites and Pfizer.

This new resource houses informative research-related articles, guidance on how to improve clinical trial quality, and up-to-date educational tools to enhance the overall clinical research experience for investigators. The interactive features available through INVESTIGATE encourage researchers to network with peers across the world and allow researchers to provide a continuous feedback loop when it comes to their own clinical trial experience through helpful surveys.

By providing researchers with this rich information and new resources, Pfizer intends to continue developing effective relationships with investigator sites to ensure the highest standards of clinical trial quality are met. Learn more by registering at http://investigate.pfizer.com.